Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neuroma 1Head and Neck Neoplasms 1Chronic Pain 1

Interventions

pembrolizumab 4Cisplatin 4Blood Specimen Collection 4Cyclophosphamide 3130-nm albumin-bound paclitaxel 3fludarabine 2Tissue Banks 2Surgical Procedures, Operative 2Nivolumab 2Docetaxel 2tislelizumab 1fludarabine phosphate 1cemiplimab 1Therapeutics 1Surgical Flaps 1Standard of Care 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation Dose Hypofractionation 1Neoadjuvant Therapy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Low-Level Light Therapy 1Ketamine 1Immune Checkpoint Inhibitors 1Gastroscopy 1Etoposide 1Electric Stimulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Head and Neck Neoplasms × Botulinum Toxins, Type A × Clear all
NCT06530524 2024-07-31

Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

Sir Mortimer B. Davis - Jewish General Hospital

Phase 2 Not yet recruiting
50 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡